Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and Sonoma Biotherapeutics, Inc., a ...

Five-agent AI team could speed clinical trial design using real-world patient records

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
JD Supra

HHS “Operation TrialBlazer”: FDA Moves to Accelerate and Modernize Clinical Development

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
Regulatory Affairs Professionals Society

FDA plans rules to rein in drug ads, enable proactive release of CRLs, and more

The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
Pharmaceutical Technology

De-risking drug formulation with AI predictive modelling

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

Building Clinical Software For A World That Changes Faster Than Code

In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...
Medical Marketing & Media

As oncology competition intensifies, differentiation moves upstream

Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...

Palisade Bio: A Unique MoA Targeting The UC And Crohn's Disease Markets

Palisade Bio offers a speculative early-stage opportunity, advancing PALI-2108, a gut-restricted PDE4 inhibitor for UC and ...
The Manila Times

Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection

Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...
The Manila Times

Sapu Nano Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

SAN DIEGO, US - Media OutReach Newswire - 9 July 2026 - Sapu Nano (US) LLC, a clinical-stage biotechnology company developing the proprietary Deciparticle™ nanomedicine platform, today announced that ...

RoslinCT and BlueRock Therapeutics Partner to Expand Access to Clinical-Grade Pluripotent Cell Lines for Cell Therapy Developers

RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization, today announced a strategic partnership with BlueRock Therapeutics, a leader in stem cell therapeutic ...

SAI-DA 1.0 | GEOTA Platform: Revolutionizing Drug R&D with Digital Computing Power

Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...